Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» AbbVie
AbbVie
AbbVie claims first FDA okay for presbyopia drug therapy
Pharmaforum
Mon, 11/1/21 - 10:59 am
AbbVie
FDA
presbyopia
AGN-190584
Even AbbVie CEO can't confirm Rinvoq's sales as FDA mulls JAK label
Fierce Pharma
Mon, 11/1/21 - 10:55 am
AbbVie
Pharma CEOs
Rick Gonzalez
Rinvoq
FDA
Merck's Keytruda close to becoming top-selling drug in the world
Beckers Hospital Review
Mon, 11/1/21 - 10:39 am
Merck
Keytruda
AbbVie
Humira
drug sales
AbbVie preps filings after ABBV-951 tops oral Parkinson’s drugs in trial
Pharmaforum
Sat, 10/30/21 - 10:48 pm
AbbVie
ABV-951
Parkinson's Disease
clinical trials
AbbVie Says Cariprazine Met Primary Endpoint In Phase 3 Study For Major Depressive Disorder
NASDAQ
Sat, 10/30/21 - 10:43 pm
AbbVie
clinical trials
cariprazine
major depressive disorder
AbbVie (ABBV) Tops Q3 Earnings Estimates
Zacks.com
Fri, 10/29/21 - 10:55 am
AbbVie
earnings
Positive Results in Hand, AbbVie Eyes Potential Approval for Parkinson’s Treatment
BioSpace
Thu, 10/28/21 - 10:16 pm
AbbVie
Parkinson's Disease
ABBV-951
clinical trials
Buckle up AbbVie, Amgen: Biohaven's oral CGRP drug is gaining traction in migraine, doctors’ survey shows
Fierce Pharma
Fri, 10/22/21 - 12:42 pm
Biohaven
migraines
Nurtec ODT
Amgen
AbbVie
Boehringer's interchangeable tag for Humira biosim is a 'landmark' win for the field: analyst
Fierce Pharma
Tue, 10/19/21 - 11:59 am
Boehringer Ingelheim
Humira
biosimilars
interchangeable biosimilars
Cyltezo
AbbVie
patents
Boehringer wins 'interchangeable' status for Humira copy, strengthening competitive threat
BioPharma Dive
Mon, 10/18/21 - 10:55 pm
Boehringer Ingelheim
AbbVie
Humira
interchangeable biosimilars
biosimilars
Cyltezo
FDA
Regeneron, Novo Nordisk, Lilly and AbbVie stake claims on September's list of top TV ad spenders
Fierce Pharma
Mon, 10/18/21 - 10:49 pm
Regeneron
Novo Nordisk
Eli Lilly
AbbVie
television ads
DTC ads
diabetes
immunology
Revance's Botox rival turned away by FDA after inspectors flagged manufacturing 'deficiencies'
Fierce Pharma
Mon, 10/18/21 - 11:10 am
Revance Therapeutics
FDA
daxibotulinumtoxinA
Botox
Daxi
AbbVie
AbbVie's Botox patent lawsuit is 'very unlikely to derail' Revance's rival launch: analysts
Fierce Pharma
Mon, 10/11/21 - 09:46 pm
AbbVie
Botox
patents
ReVance
Alvotech scores in AbbVie trade secrets case, but the Humira patent fight will stretch into next year
Fierce Pharma
Fri, 10/8/21 - 10:32 am
Alvotech
AbbVie
patents
Humira
trade secrets
biosimilars
AbbVie touts more Rinvoq data in inflammatory spinal arthritis as it awaits key FDA decisions
Fierce Pharma
Thu, 10/7/21 - 12:25 pm
AbbVie
Rinvoq
FDA
inflammatory spinal arthritis
AbbVie’s Qulipta Set to Become Blockbuster in the Migraine Market
Clinical Trials Arena
Sun, 10/3/21 - 08:11 pm
AbbVie
Qulipta
migraines
FDA
AbbVie, industry group push for international compromise on when trial investigators should receive unblinded data
Endpoints
Thu, 09/30/21 - 11:07 pm
AbbVie
TransCelerate BioPharma
FDA
clinical trials
IND safety reports
AbbVie closes in on Biohaven with new migraine prevention OK for oral CGRP drug
Endpoints
Wed, 09/29/21 - 11:04 am
AbbVie
Qulipta
migraines
Allergan
Biohaven
FDA
Oncology the focus for big pharma catalysts
EP Vantage
Tue, 09/28/21 - 11:19 am
Big Pharma
cancer
oncology
Merck
Keytruda
AbbVie
Vraylar
Gilead Sciences
Trodelvy
Sanofi
Sarclisa
Novartis
ligelizumab
Why AbbVie Just Made a $1.8 Billion Gene Therapy Deal
Motley Fool
Sat, 09/25/21 - 11:00 pm
AbbVie
Regenxbio
gene therapy
wet age-related macular degeneration
Pages
« first
‹ previous
…
12
13
14
15
16
17
18
19
20
…
next ›
last »